370: Pharma sours on the U.K., plus biotech M&A's quiet roll
The Readout Loud
00:00
Why Pharma Is Pulling Back from the U.K.
Andrew Joseph outlines VPAC pricing tensions, company pullbacks, big U.S. investment pledges, shifting focus to the U.S. and China, and policy options to revive the U.K. life sciences sector.
Transcript
Play full episode
